WGA-coated yttrium oxide beads enable an imaging-based adenosine 2a receptor binding scintillation proximity assay suitable for high throughput screening

被引:9
作者
Bryant, R
McGuinness, D
Turek-Etienne, T
Guyer, D
Yu, LM
Howells, L
Caravano, J
Zhai, Y
Lachowicz, J
机构
[1] Schering Plough Corp, Res Inst, Kenilworth, NJ 07033 USA
[2] Amersham Biosci Corp, Piscataway, NJ USA
关键词
D O I
10.1089/1540658041410713
中图分类号
Q5 [生物化学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Adenosine receptors belong to the superfamily of G protein-coupled receptors and are involved in a variety of physiologic functions. Traditionally, binding assays to detect adenosine 2a (A2a) antagonists and agonists have used filtration methods that are cumbersome to run and not amenable to HTS. We developed scintillation proximity assays (SPA(TM)) utilizing HEK293 RBHA2AM cell membranes, either wheat germ agglutinin (WGA)-coated yttrium silicate (YSi) or red-shifted yttrium oxide (YO) beads and the A2a-selective radioligand [H-3]SCH 58261. Both beads gave windows (total binding/nonspecific binding) of >5 and K-d values of 2-3 nM for the radioligand, in agreement with results obtained by filtration. In contrast, WGA-polyvinyltoluene as well as other bead types had windows of <3 and significant radioligand binding to the uncoated beads. A 384-well WGA-YO bead SPA was optimized utilizing a LEADseeker(TM) imaging system and an automated trituration process for dispensing the dense yttrium-based beads. Signals were stable after 4 h, and Z' values were 0.7-0.8. The LEADseeker imaging assay tolerated 2% dimethyl sulfoxide and generated IC50 values of 3-5 nM for the A2a antagonist CGS 15943, comparable to that obtained by the filtration method. A number of adenosine and xanthine analogues were identified as hits in the Library of Pharmacologically Active Compounds (LOPAC). This imaging-based A2a SPA enables HTS and is a major improvement over the filtration method.
引用
收藏
页码:290 / 299
页数:10
相关论文
共 17 条
[1]
Cheng Y. C., 1973, BIOCHEM PHARMACOL, V22, P413
[2]
MOLECULAR-CLONING OF A NOVEL ADENOSINE RECEPTOR GENE FROM RAT-BRAIN [J].
CHERN, YJ ;
KING, K ;
LAI, HL ;
LAI, HT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 185 (01) :304-309
[3]
COOK L, 2001, SOC BIOM SCREEN 7 AN
[4]
Characterization of human A(2A) adenosine receptors with the antagonist radioligand [H-3]-SCH 58261 [J].
Dionisotti, S ;
Ongini, E ;
Zocchi, C ;
Kull, B ;
Arslan, G ;
Fredholm, BB .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 121 (03) :353-360
[5]
Tissue distribution of adenosine receptor mRNAs in the rat [J].
Dixon, AK ;
Gubitz, AK ;
Sirinathsinghji, DJS ;
Richardson, PJ ;
Freeman, TC .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (06) :1461-1468
[6]
DOHLMAN HG, 1987, KIDNEY INT, V32, pS2
[7]
MOLECULAR-CLONING OF THE RAT ADENOSINE-A2 RECEPTOR - SELECTIVE COEXPRESSION WITH D2-DOPAMINE RECEPTORS IN RAT STRIATUM [J].
FINK, JS ;
WEAVER, DR ;
RIVKEES, SA ;
PETERFREUND, RA ;
POLLACK, AE ;
ADLER, EM ;
REPPERT, SM .
MOLECULAR BRAIN RESEARCH, 1992, 14 (03) :186-195
[8]
FRIEDMAN JE, 2002, IBC 6 ANN C ASS DEV
[9]
Development of scintillation-proximity assays for alpha adrenoceptors [J].
Gobel, J ;
Saussy, DL ;
Goetz, AS .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1999, 42 (04) :237-244
[10]
Adenosine A2A antagonist:: A novel antiparkinsonian agent that does not provoke dyskinesia in Parkinsonian monkeys [J].
Kanda, T ;
Jackson, MJ ;
Smith, LA ;
Pearce, RKB ;
Nakamura, J ;
Kase, H ;
Kuwana, Y ;
Jenner, P .
ANNALS OF NEUROLOGY, 1998, 43 (04) :507-513